Patents Assigned to New Life Pharmaceuticals Inc.
  • PREVENTION OF OVARIAN CANCER BY ADMINISTRATION OF PRODUCTS THAT INDUCE BIOLOGICAL EFFECTS IN THE OVARIAN EPITHELIUM
    Publication number: 20080045488
    Abstract: The present invention relates to compositions and methods for preventing the development of epithelial ovarian cancer by administering compounds in an amount capable of regulating TGF-? expression in the ovarian epithelium and/or capable of optimally altering expression of other surrogate biomarkers identified by microarray technology. HRT and OCP regimens comprising such compositions and methods are disclosed.
    Type: Application
    Filed: June 29, 2007
    Publication date: February 21, 2008
    Applicant: New Life Pharmaceuticals Inc.
    Inventor: Gustavo RODRIGUEZ
  • Composition containing Vitamin D and phytoestrogens
    Publication number: 20070275940
    Abstract: The present invention relates to compositions and methods for preventing the development of epithelial ovarian cancer by administering compounds in an amount capable of regulating TGF-? expression in the ovarian epithelium and/or capable of optimally altering expression of other surrogate biomarkers identified by microarray technology. HRT and OCP regimens comprising such compositions and methods are disclosed.
    Type: Application
    Filed: April 27, 2007
    Publication date: November 29, 2007
    Applicant: New Life Pharmaceuticals Inc.
    Inventor: Gustavo RODRIGUEZ
  • Prevention of ovarian cancer by administration of a Vitamin D compound
    Patent number: 7053074
    Abstract: The present invention relates to methods for preventing the development of epithelial ovarian cancer by administering a Vitamin D compound in an amount capable of increasing apoptosis in non-neoplastic ovarian epithelial cells of the female subject.
    Type: Grant
    Filed: January 18, 2002
    Date of Patent: May 30, 2006
    Assignee: New Life Pharmaceuticals, Inc.
    Inventors: Gustavo C. Rodriguez, Regina Salas Whitaker
  • Prevention of ovarian cancer by administration of progestin products
    Patent number: 6977250
    Abstract: The present invention relates to methods for preventing the development of epithelial ovarian cancer by administering progestin products, either alone or in combination with other agents such as estrogen products.
    Type: Grant
    Filed: September 17, 2001
    Date of Patent: December 20, 2005
    Assignee: New Life Pharmaceuticals Inc.
    Inventor: Gustavo C. Rodriguez
  • Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
    Patent number: 6511970
    Abstract: The present invention relates to compositions and methods for preventing the development of epithelial ovarian cancer by administering compounds in an amount capable of increasing TGF-&bgr; expression in the ovarian epithelium. HRT and OCP regimens comprising such compositions and methods are disclosed.
    Type: Grant
    Filed: September 28, 2000
    Date of Patent: January 28, 2003
    Assignee: New Life Pharmaceuticals Inc.
    Inventor: Gustavo C. Rodriguez
  • Prevention of ovarian cancer by administration of a vitamin D compound
    Patent number: 6444658
    Abstract: The present invention relates to methods for preventing the development of epithelial ovarian cancer by administering a Vitamin D compound in an amount capable of increasing apoptosis in non-neoplastic ovarian epithelial cells of the female subject.
    Type: Grant
    Filed: January 7, 2000
    Date of Patent: September 3, 2002
    Assignee: New Life Pharmaceuticals Inc.
    Inventors: Gustavo C. Rodriguez, Regina Salas Whitaker
  • Prevention of ovarian cancer by administration of a vitamin D compound
    Patent number: 6407082
    Abstract: The present invention relates to methods for preventing the development of epithelial ovarian cancer by administering a Vitamin D compound in an amount capable of increasing apoptosis in non-neoplastic ovarian epithelial cells of the female subject.
    Type: Grant
    Filed: January 7, 2000
    Date of Patent: June 18, 2002
    Assignee: New Life Pharmaceuticals Inc.
    Inventors: Gustavo C. Rodriguez, Regina Salas Whitaker
  • Prevention of ovarian cancer by administration of progestin products
    Publication number: 20020028795
    Abstract: The present invention relates to methods for preventing the development of epithelial ovarian cancer by administering progestin products, either alone or in combination with other agents such as estrogen products.
    Type: Application
    Filed: September 17, 2001
    Publication date: March 7, 2002
    Applicant: New Life Pharmaceuticals Inc.
    Inventor: Gustavo C. Rodriguez
  • Prevention of ovarian cancer by administration of progestin products
    Patent number: 6319911
    Abstract: The present invention relates to methods for preventing the development of epithelial ovarian cancer by administering progestin products, either alone or in combination with other agents such as estrogen products.
    Type: Grant
    Filed: July 16, 1998
    Date of Patent: November 20, 2001
    Assignee: New Life Pharmaceuticals Inc.
    Inventor: Gustavo C. Rodriguez
  • Prevention of ovarian cancer by administration of progestin products
    Patent number: 6310054
    Abstract: The present invention relates to methods for preventing the development of epithelial ovarian cancer by administering progestin products, either alone or in combination with other agents such as estrogen products.
    Type: Grant
    Filed: December 16, 1999
    Date of Patent: October 30, 2001
    Assignee: New Life Pharmaceuticals Inc.
    Inventor: Gustavo C. Rodriguez
  • Prevention of ovarian cancer by administration of a Vitamin D compound
    Patent number: 6034074
    Abstract: The present invention relates to methods for preventing the development of epithelial ovarian cancer by administering a Vitamin D compound in an amount capable of increasing apoptosis in non-neoplastic ovarian epithelial cells of the female subject.
    Type: Grant
    Filed: June 11, 1997
    Date of Patent: March 7, 2000
    Assignee: New Life Pharmaceuticals Inc.
    Inventors: Gustavo C. Rodriguez, Regina Salas Whitaker
  • Prevention of ovarian cancer by administration of progestin products
    Patent number: 6028064
    Abstract: The present invention relates to methods for preventing the development of epithelial ovarian cancer by administering progestin products, either alone or in combination with other agents such as estrogen products.
    Type: Grant
    Filed: September 13, 1996
    Date of Patent: February 22, 2000
    Assignee: New Life Pharmaceuticals Inc.
    Inventors: Gustavo C. Rodriguez, Claude L. Hughes, Jr.